The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025
Whether you're new to GLP-1s, currently on one, or restarting after a break, our physician will tailor a safe plan, including the right restart dose if it's been a while
Losing 5% to 10% of body weight through diet and exercise reduces the risk of cardiovascular disease, but diet and exercise alone are not always guaranteed to address the issue
Across both preclinical models and human observational studies, GLP-1 RA therapy has frequently been associated with shifts toward a more eubiotic microbial configuration
A sensible framework: give an acute soft-tissue course a couple of weeks before drawing conclusions, and give tendon, ligament, or nerve work considerably longer before deciding it is or is not helping